Invetx, Inc. announced it raised $55.5 Million in an initial filing from an offering of $55.5 Million

Company

Location

About

t Invetx, we bring the best of biopharma to animal health. We are building the world’s premier animal health biotechnology innovation platform for protein-based therapeutics. Working closely with best-in-class biotechnology companies, major investors and an extensive network of industry experts, we are focused on guiding the development of an exciting portfolio of therapies and technologies to deliver the future of animal care. Our network includes experts in both animal and human health, veterinary scientists and clinicians. Our vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.